These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 26762267)

  • 1. MiR-548c impairs migration and invasion of endometrial and ovarian cancer cells via downregulation of Twist.
    Sun X; Cui M; Zhang A; Tong L; Wang K; Li K; Wang X; Sun Z; Zhang H
    J Exp Clin Cancer Res; 2016 Jan; 35():10. PubMed ID: 26762267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-219-5p inhibits the proliferation, migration, and invasion of epithelial ovarian cancer cells by targeting the Twist/Wnt/β-catenin signaling pathway.
    Wei C; Zhang X; He S; Liu B; Han H; Sun X
    Gene; 2017 Dec; 637():25-32. PubMed ID: 28890378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-326 regulates EMT and metastasis of endometrial cancer through targeting TWIST1.
    Liu W; Zhang B; Xu N; Wang MJ; Liu Q
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3787-3793. PubMed ID: 28975990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-543 suppresses endometrial cancer oncogenicity via targeting FAK and TWIST1 expression.
    Bing L; Hong C; Li-Xin S; Wei G
    Arch Gynecol Obstet; 2014 Sep; 290(3):533-41. PubMed ID: 24699721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-543 functions as tumor suppressor in ovarian cancer by targeting TWIST1.
    Yu Q; Zhang Z; He B; Wang H; Shi P; Li Y
    J Biol Regul Homeost Agents; 2020; 34(1):101-110. PubMed ID: 32148011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-15a-3p suppresses the growth and metastasis of ovarian cancer cell by targeting Twist1.
    Fan B; Chen LP; Yuan YH; Xiao HN; Lv XS; Xia ZY
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):1934-1946. PubMed ID: 30915736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-1236 regulates hypoxia-induced epithelial-mesenchymal transition and cell migration/invasion through repressing SENP1 and HDAC3.
    Chen SY; Teng SC; Cheng TH; Wu KJ
    Cancer Lett; 2016 Aug; 378(1):59-67. PubMed ID: 27177472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-186 affects the proliferation, invasion and migration of human gastric cancer by inhibition of Twist1.
    Cao C; Sun D; Zhang L; Song L
    Oncotarget; 2016 Nov; 7(48):79956-79963. PubMed ID: 27835599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. microRNA-335 inhibits colorectal cancer HCT116 cells growth and epithelial-mesenchymal transition (EMT) process by targeting Twist1.
    Wang J; Wang X; Liu F; Fu Y
    Pharmazie; 2017 Aug; 72(8):475-481. PubMed ID: 29441907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-98 inhibits expression of TWIST to prevent progression of non-small cell lung cancers.
    Zhou H; Huang Z; Chen X; Chen S
    Biomed Pharmacother; 2017 May; 89():1453-1461. PubMed ID: 28415380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-96 promotes tumor proliferation and invasion by targeting RECK in breast cancer.
    Zhang J; Kong X; Li J; Luo Q; Li X; Shen L; Chen L; Fang L
    Oncol Rep; 2014 Mar; 31(3):1357-63. PubMed ID: 24366472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-106b modulates epithelial-mesenchymal transition by targeting TWIST1 in invasive endometrial cancer cell lines.
    Dong P; Kaneuchi M; Watari H; Sudo S; Sakuragi N
    Mol Carcinog; 2014 May; 53(5):349-59. PubMed ID: 24002805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactivation of epigenetically silenced miR-124 reverses the epithelial-to-mesenchymal transition and inhibits invasion in endometrial cancer cells via the direct repression of IQGAP1 expression.
    Dong P; Ihira K; Xiong Y; Watari H; Hanley SJ; Yamada T; Hosaka M; Kudo M; Yue J; Sakuragi N
    Oncotarget; 2016 Apr; 7(15):20260-70. PubMed ID: 26934121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-335 represents an invasion suppressor gene in ovarian cancer by targeting Bcl-w.
    Cao J; Cai J; Huang D; Han Q; Yang Q; Li T; Ding H; Wang Z
    Oncol Rep; 2013 Aug; 30(2):701-6. PubMed ID: 23708561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysregulation of microRNA-204 mediates migration and invasion of endometrial cancer by regulating FOXC1.
    Chung TK; Lau TS; Cheung TH; Yim SF; Lo KW; Siu NS; Chan LK; Yu MY; Kwong J; Doran G; Barroilhet LM; Ng AS; Wong RR; Wang VW; Mok SC; Smith DI; Berkowitz RS; Wong YF
    Int J Cancer; 2012 Mar; 130(5):1036-45. PubMed ID: 21400511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-200a inhibits CD133/1+ ovarian cancer stem cells migration and invasion by targeting E-cadherin repressor ZEB2.
    Wu Q; Guo R; Lin M; Zhou B; Wang Y
    Gynecol Oncol; 2011 Jul; 122(1):149-54. PubMed ID: 21529905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Upregulation of miR-183-5p is responsible for the promotion of apoptosis and inhibition of the epithelial-mesenchymal transition, proliferation, invasion and migration of human endometrial cancer cells by downregulating Ezrin.
    Yan H; Sun BM; Zhang YY; Li YJ; Huang CX; Feng FZ; Li C
    Int J Mol Med; 2018 Nov; 42(5):2469-2480. PubMed ID: 30226564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-93 Promotes Epithelial-Mesenchymal Transition of Endometrial Carcinoma Cells.
    Chen S; Chen X; Sun KX; Xiu YL; Liu BL; Feng MX; Sang XB; Zhao Y
    PLoS One; 2016; 11(11):e0165776. PubMed ID: 27829043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth hormone-releasing hormone antagonist inhibits the invasiveness of human endometrial cancer cells by down-regulating twist and N-cadherin expression.
    Wu HM; Huang HY; Schally AV; Chao A; Chou HH; Leung PC; Wang HS
    Oncotarget; 2017 Jan; 8(3):4410-4421. PubMed ID: 28032599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-133b inhibits proliferation and invasion of ovarian cancer cells through Akt and Erk1/2 inactivation by targeting epidermal growth factor receptor.
    Liu X; Li G
    Int J Clin Exp Pathol; 2015; 8(9):10605-14. PubMed ID: 26617770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.